What is the clinical evidence from this study?

Study design: Review. Population: Arrhythmogenic Right Ventricular Dysplasia.

What question did this study set out to answer?

To summarize and critically evaluate current diagnostic criteria, genetic insights, pathological features, and therapeutic strategies for arrhythmogenic right ventricular dysplasia.

January 1, 2001Current Opinion in Cardiology

Arrhythmogenic Right Ventricular Dysplasia: cardiomyopathy current opinions on diagnostic and therapeutic aspects

View Full Paper

Ask AI

Bookmark

Key result

Arrhythmogenic Right Ventricular Dysplasia is a genetic cardiomyopathy characterized by fibrous-adipose substitution of the right ventricular myocardium, associated with ventricular arrhythmias and sudden death.

Population

Patients with Arrhythmogenic Right Ventricular Dysplasia (ARVD) / Cardiomyopathy

Design

Review

Authors

FNF NaccarellaItalian Institute of Telemedicine GNGerald V. NaccarelliElectrophysiology RFRosella FattoriIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola

Discussion

Member takes

Implication

Highlights ARVD diagnostic vigilance for clinicians; leaves open refined genetic risk models for research.

Key Points

To summarize and critically evaluate current diagnostic criteria, genetic insights, pathological features, and therapeutic strategies for arrhythmogenic right ventricular dysplasia.
Reviewed clinical literature and institutional experience regarding arrhythmogenic right ventricular dysplasia (ARVD).
Evaluated diagnostic criteria, electrocardiographic characteristics across early and advanced stages, and endomyocardial biopsy and pathology specimens.
Pathology demonstrates progressive fibrofatty replacement predominantly affecting the right ventricular myocardium and occasionally the left ventricle.
Clinical manifestations span frequent ventricular ectopy to sustained ventricular tachycardia with left bundle branch block morphology, carrying substantial risk of sudden cardiac death.

Structured PICO

Population

Patients with Arrhythmogenic Right Ventricular Dysplasia (ARVD) / Cardiomyopathy

This review provides a comprehensive overview of the diagnostic criteria, clinical manifestations, and anatomical abnormalities associated with Arrhythmogenic Right Ventricular Dysplasia.

Cite This Study

Naccarella et al. (2001) conducted a review in Arrhythmogenic Right Ventricular Dysplasia. Arrhythmogenic Right Ventricular Dysplasia is a genetic cardiomyopathy characterized by fibrous-adipose substitution of the right ventricular myocardium, associated with ventricular arrhythmias and sudden death.

synapsesocial.com/papers/6a1c8f60107ed6dc7cc3fca8 https://doi.org/10.1097/00001573-200101000-00002

Topics

Cardiomyopathy Cardiac amyloidosis

View Full Paper

Ask AI

Bookmark

Arrhythmogenic Right Ventricular Dysplasia: cardiomyopathy current opinions on diagnostic and therapeutic aspects

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Topics

Arrhythmogenic Right Ventricular Dysplasia: cardiomyopathy current opinions on diagnostic and therapeutic aspects

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider